UK markets close in 2 hours 14 minutes
  • FTSE 100

    6,886.16
    +4.57 (+0.07%)
     
  • FTSE 250

    17,006.15
    +215.75 (+1.28%)
     
  • AIM

    801.81
    +3.42 (+0.43%)
     
  • GBP/EUR

    1.1344
    +0.0020 (+0.18%)
     
  • GBP/USD

    1.1058
    -0.0065 (-0.59%)
     
  • BTC-GBP

    17,417.03
    -74.15 (-0.42%)
     
  • CMC Crypto 200

    440.77
    -5.21 (-1.17%)
     
  • S&P 500

    3,640.47
    -78.57 (-2.11%)
     
  • DOW

    29,225.61
    -458.13 (-1.54%)
     
  • CRUDE OIL

    80.22
    -1.01 (-1.24%)
     
  • GOLD FUTURES

    1,671.70
    +3.10 (+0.19%)
     
  • NIKKEI 225

    25,937.21
    -484.84 (-1.83%)
     
  • HANG SENG

    17,222.83
    +56.96 (+0.33%)
     
  • DAX

    12,058.21
    +82.66 (+0.69%)
     
  • CAC 40

    5,718.97
    +42.10 (+0.74%)
     

$40.7 Billion Worldwide Biobanks Industry to 2027 - Demand for Temperature Control Systems to Gain Strength

·5-min read
Company Logo
Company Logo

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Biobanks Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2017-2027 Segmented By Type, By Sample Type, By Application, By End User, By Region" report has been added to ResearchAndMarkets.com's offering.

The Global Biobanks Market stood at USD40.70 billion in 2021 and is expected to grow at an impressive rate of 8.22% during the forecast period. This can be ascribed to the growing investments and research & development in advanced therapies such as cancer genomic studies, personalized medicine, among others.

Biobanks play a pivotal role in disease diagnosis and development of a treatment or drug. The COVID-19 pandemic crisis has significantly increased the demand for biobanks worldwide. During the pandemic crisis various new specialized biobanks, focusing on COVID-19 were developed for research & development activities. For instance, in July 2021, Tulane University announced a new COVID-19 biobank containing blood & cell samples from survivors.

Regenerative Medicine Applications for Biobanking Market will drive the Market

Biobanks Market contributes to the advancement of biomedical and translational research by collecting and preserving biological samples such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this information is then used for diagnosis, prognosis, and drug response prediction.

The increase in the number of research activities in this area is a major market driver. The availability of government financing for regenerative medicine, stem cell treatments, and cell and gene therapy are fueling this segment's research. Aside from that, the growing trend of cord blood banking will help this market segment develop. Future possibilities are predicted to include breakthroughs in orthopaedic therapies utilising stem cells.

Stakeholders Shifting Focus from Sample-driven to Data-driven Strategies

Precision medicine research is gaining traction as a result of the digital revolution. Precision medicine research and clinical data are also inextricably linked. Although there are times when there are modest connections between the two variables. Because the availability of data on well-characterized and high-quality samples is of relevance to healthcare organizations, this works as a profitable opportunity for stakeholders in the biobanking market.

Artificial intelligence (AI) and big data analytics are being introduced into the biobanking landscape in order to develop strong correlations between precision medicine research and clinical data. This has aided faster research, which has had a positive impact on the delivery of new pharmaceuticals in the healthcare industry. As a result, there is a growing demand in the biobanking industry for increased informatics capabilities.

Demand for Temperature Control Systems to Gain Strength in Biobanks Market

Biobanks are in high demand to preserve a variety of biospecimen, from blood to tissues, cells, and nucleic acids, due to the growing trend of personalized treatments to reduce chronic disease-related mortality rates.

As major manufacturers are focusing their efforts on the release of freezers and refrigerators, cryogenic storage systems, and other equipment for the storage of biobank samples, the market is expected to place a greater emphasis on temperature control systems, boosting global demand for Biobanks. The equipment segment is being driven by an increase in the number of Biobanks in several countries, as well as a desire for sophisticated biobanking equipment.

Market Segmentation

The Global Biobanks Market is segmented based on Type, Sample Type, Application, End-User, Region, and by Company. Based on Type, the market is further fragmented into Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks and Others. Based on Sample Type, the market is segmented into Blood Products, Biological fluids, Nucleic Acid, Cell Lines and Others.

Also, segmentation of the market based on the Application is done into Therapeutics, Drug Discovery, Clinical Diagnostic and Clinical Research. Based on End-User, the market is further fragmented into Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinics and Others. The market analysis also studies the regional segmentation divided among North American region, Asia-Pacific region, European region, Middle East & African region, South American region.

The North America dominated the market in 2021 and is projected to maintain its dominance during the forecast period. United States market for biobanks was the largest and stood at USD9.03 billion in 2021. This can be ascribed to the large number of biobanks establishments in the country.

Company Profiles

Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Avantor, Inc., Thermo Fisher Scientific, Inc, Tecan Trading AG, QIAGEN N.V. Hamilton Company, ProMedDx, LLC, ISENET Biobanking S.r.l., are among the major market players in the Global Biobanks Market.

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Biobanks Market

5. Voice of Customer
5.1. Factors Contributing to Demand for Biobanks
5.2. Source of Information
5.3. Preference for Biobanks, By Type
5.4. Unmet Needs/Challenges

6. Global Biobanks Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks, Others)
6.2.2. By Sample Type (Blood Products, Biological fluids, Nucleic Acid, Cell Lines, Others
6.2.3. By Application (Therapeutics, Drug Discovery, Clinical Diagnostics, Clinical Research
6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Product Market Map

7. North America Biobanks Market Outlook

8. Europe Biobanks Market Outlook

9. Asia-Pacific Biobanks Market Outlook

10. South America Biobanks Market Outlook

11. Middle East and Africa Biobanks Market Outlook

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Danaher Corporation
14.2. Merck KGaA
14.3. Becton, Dickinson, and Company
14.4. Avantor, Inc.
14.5. Thermo Fisher Scientific, Inc
14.6. Tecan Trading AG
14.7. QIAGEN N.V.
14.8. Hamilton Company
14.9. ProMedDx, LLC
14.10. ISENET Biobanking S.r.l

15. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/hox6y9

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900